AI Generated
May 9, 2026, 22:55
Romiplostim Versus Placebo in the Management of Chemotherapy-Induced Thrombocytopenia – Transfusion Evidence Library
Transfusion Evidence Library, shared a post on LinkedIn about a recent article by Al-Samkari H et al. published in NEJM, adding:
”New from the Transfusion Evidence Alert:
Romiplostim versus Placebo for Chemotherapy-Induced Thrombocytopenia.”
Title: Romiplostim versus Placebo for Chemotherapy-Induced Thrombocytopenia
Authors: Hanny Al-Samkari, César Muñoz, Çağdaş Geredeli, Ioannis Korantzis, Bárbara González Astorga, Can Arslan, João F. Cordeiro Camargo, Franck Scotté , Gilberto Borges, Kai Wang, Martin Kuter, Gerald A. Soff
Stay updated on all scientific advances with Hemostasis Today.
Bárbara González Astorga
Çağdaş Geredeli
Can Arslan
César Muñoz
Franck Scotté
Gerald A. Soff
Gilberto Borges
Hanny Al-Samkari
Health
Hematology
Hemophilia
Hemostasis
Hemostasis News
Hemostasis Today
Ioannis Korantzis
João F. Cordeiro Camargo
Kai Wang
Martin Kuter
Medicine
thrombosis
Transfusion Evidence Library
-
Sep 30, 2026, 01:52Javed Anees: DADA2 – When a Young Stroke Is More Than a Stroke
-
Sep 30, 2026, 01:51How a Venous Thrombus Becomes Revascularized – ISTH
-
Sep 29, 2026, 22:45Victor Agunyego: Paracetamol – The Most Common Drug We Underestimate
-
Sep 29, 2026, 22:42Nova Sinclair: Advancing the Future of Hematology – Meet Our 2027 Organizing Committee
-
Sep 29, 2026, 22:41Lorenz Räber: Intracoronary Imaging in PCI – Why, When, How, and Which Modality?
-
Sep 29, 2026, 22:31Selma Turkovic: Pleased to Deliver the Opening Presentation at Kingston Hospital
-
Sep 29, 2026, 22:31Miguel Teran: Ultrasound and Simulation in Arterial Blood Sampling
-
Sep 29, 2026, 22:28Mohammad Refaei: Navigating Your Career in Hematology From Training to Practice
-
Sep 29, 2026, 22:27Matteo Foschi: 10 Clinical Pearls for Antithrombotic Therapy in Secondary Stroke Prevention